Previous close | 7.40 |
Open | N/A |
Bid | 7.50 |
Ask | 10.50 |
Strike | 35.00 |
Expiry date | 2024-06-21 |
Day's range | 7.40 - 7.70 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Review Qiagen's (QGEN) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
QCI Secondary Analysis a cloud-based software directly integrated with QCI Interpret, enabling high-throughput secondary analysis of clinical next-generation sequencing data // New software advances precision medicine by enabling smaller and decentralized labs to adopt NGS testing with efficiency, consistency and confidence // Combination of QCI Secondary Analysis and QCI Interpret provide a secure and compliant environment for trusted and scalable bioinformatics workflows for oncology and inher
It's been a good week for Qiagen N.V. ( NYSE:QGEN ) shareholders, because the company has just released its latest...